Tokyo, Japan

Hidetake Kurihara



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hidetake Kurihara: Innovator in Glomerulopathy Treatment

Introduction: Hidetake Kurihara, based in Tokyo, Japan, is a notable inventor recognized for his contributions to medical innovation. With a total of two patents, his work primarily focuses on innovative solutions for treating glomerulopathy, a serious kidney condition.

Latest Patents: Kurihara's latest patents include a composition aimed at treating or preventing glomerulopathy. The specific details of the patent mention a compound of the formula (I) that serves as a therapeutic or prophylactic agent for this condition. These developments signify a significant advancement in medical treatment options for patients suffering from kidney diseases.

Career Highlights: Hidetake Kurihara has established his career at Shionogi & Company Limited, a prominent pharmaceutical entity devoted to enhancing health through innovative medicines. His expertise and research have contributed to the company's mission of delivering impactful healthcare solutions.

Collaborations: Throughout his career, Kurihara has collaborated with notable colleagues, including Fumihiko Watanabe and Yoshinori Tamura. These partnerships have bolstered the innovative capacity of their projects, leading to advancements that can potentially transform treatment protocols in the medical field.

Conclusion: Hidetake Kurihara stands out as a dedicated inventor whose work in the treatment of glomerulopathy not only showcases his commitment to medical innovation but also highlights the potential for new therapies that can significantly improve patient care. His contributions at Shionogi & Company Limited continue to pave the way for future advancements in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…